Managing cancer patients during COVID-19 pandemic: a North African oncological center experience.
Betacoronavirus
COVID-19
COVID-19 Testing
Cancer Care Facilities
/ organization & administration
Clinical Laboratory Techniques
Continuity of Patient Care
Coronavirus Infections
/ diagnosis
Disease Management
Female
Health Services Accessibility
Hospital Departments
/ statistics & numerical data
Hospital Units
/ statistics & numerical data
Humans
Infection Control
/ organization & administration
Infectious Disease Transmission, Patient-to-Professional
/ prevention & control
Infectious Disease Transmission, Professional-to-Patient
/ prevention & control
Male
Mass Screening
/ organization & administration
Middle Aged
Morocco
Neoplasms
/ therapy
Pandemics
/ prevention & control
Pneumonia, Viral
/ diagnosis
Retrospective Studies
SARS-CoV-2
COVID-19
cancer
prevention
Journal
The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
06
2020
accepted:
10
07
2020
entrez:
16
11
2020
pubmed:
17
11
2020
medline:
21
11
2020
Statut:
epublish
Résumé
since the first spread of the novel coronavirus (COVID-19) in Morocco in March 2020, the Moroccan Health System underwent an important pressure and remarkable efforts were spent to provide efficient reactions to this emergency. Public hospitals have set adapted strategies dedicated to overcoming the overload of COVID-19 patients, and our Oncology and Hematology Center (OHC) has implemented a flexible adapted strategy aiming to reduce the burden of COVID-19. We report our single-center experience on the detailed infection control measures undertaken to minimize virus transmission. we reviewed all patients treated at the OHC from March 2 we notified a significant decrease in patients' admissions during the lockdown period at the different units of our center. The screening area received a total of 5267 patients during our study period, with an average of 105 patients per day. Interestingly, no healthcare professional was infected and only 8 patients showed symptoms of fever and cough, and all of them had a negative test for COVID-19 (RT-PCR). Thus, the OHC is considered as a COVID-19 free center with zero cases among patients and healthcare providers. by having a 0% rate of infection, the efficiency of our measures is proven, but efforts are still needed as we have to measure the impact of this pandemic in our cancer management.
Identifiants
pubmed: 33193959
doi: 10.11604/pamj.supp.2020.35.144.24582
pii: PAMJ-35-2-144
pmc: PMC7608771
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
144Informations de copyright
Copyright: Youssouf Mohamed Ammor et al.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Clin Oncol. 2020 Jul 1;38(19):2201-2205
pubmed: 32343643
J Autoimmun. 2017 Dec;85:117-125
pubmed: 28728794
J Thorac Oncol. 2020 May;15(5):700-704
pubmed: 32114094
Lancet Oncol. 2009 Jun;10(6):589-97
pubmed: 19482247
Lancet Oncol. 2020 May;21(5):619-621
pubmed: 32220659
Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):305-311
pubmed: 32133833
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Lancet Oncol. 2020 May;21(5):629-630
pubmed: 32247319
Ann Surg. 2016 Aug;264(2):370-7
pubmed: 26445474
Ann Oncol. 2020 Jul;31(7):840-843
pubmed: 32243893
Adv Radiat Oncol. 2020 Mar 20;5(4):527-530
pubmed: 32292837
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650